Related Experiment Videos
Proliferative activity and p53 expression in primary and recurrent pterygia
1Department of Ophthalmology, Hadassah University Hospital and the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Ophthalmology
|April 26, 2001
Summary
p53 expression and high cell proliferation in pterygia do not predict recurrence. This study found no association between these factors and the regrowth of pterygium after initial treatment.
Area of Science:
- Ophthalmology
- Oncology
- Cell Biology
Background:
- Pterygium is a common ocular surface condition.
- Recurrence after surgical excision remains a clinical challenge.
- Understanding molecular markers associated with recurrence is crucial for improving outcomes.
Purpose of the Study:
- To investigate the role of p53 protein expression and cellular proliferation in primary and recurrent pterygia.
- To determine if these factors can predict pterygium recurrence.
Main Methods:
- A retrospective study comparing human pterygium tissue samples.
- Immunohistochemical analysis using MIB-1 (Ki-67) and p53 antibodies.
- Quantification of proliferative activity and p53 staining in primary, recurrent, and normal conjunctival tissues.
Main Results:
- Proliferative activity was observed in the epithelium of pterygia and normal conjunctiva.
- p53 immunoreactivity was detected in 50% of pterygia but not in normal conjunctiva.
- p53-positive pterygia exhibited higher MIB-1 positive cell counts compared to p53-negative lesions (p=0.021).
Conclusions:
- p53 expression and high proliferative activity in the pterygium epithelium are not associated with pterygium recurrence.
- These molecular markers do not appear to be reliable predictors of post-operative pterygium regrowth.